Asthma, COPD Tied to Worse COVID-19 Outcomes
Patients with active asthma or chronic obstructive pulmonary disease (COPD) are at increased risk for severe COVID-19 outcomes.
Related Articles
Special CME Offers | Special Offers for Medical Education | myCME
Special promotions, group pricing, student pricing, and military discounts are available for many courses in the myCME Marketplace.
Special CME Offers | Special Offers for Medical Education | myCME
Special promotions, group pricing, student pricing, and military discounts are available for many courses in the myCME Marketplace.
RSV Hospitalization in Young Children Much Greater Post- vs Pre-Pandemic
Researchers estimated hospitalization rates for children age 5 and under with RSV pre- and post-pandemic as well as the burden of RSV in various pediatric…
Upping Dose May Aid Smoking Cessation After Initial Treatment Failure
Benefit seen with additional six weeks of treatment after six weeks of initial failure with varenicline or nicotine replacement
Pirfenidone Has Similar Efficacy, Fewer Adverse Events Than Nintedanib for IPF
Researchers assessed the real-world efficacy and safety of idiopathic pulmonary fibrosis antifibrotics pirfenidone and nintedanib.
Quantitative Interstitial Abnormality Linked to Severe ARD in Smokers
QIA progression associated with increased odds of severe acute respiratory disease events
Pediatric COVID-19 Not Linked to New Asthma Diagnosis
Researchers assessed whether SARS-CoV-2 infection in children modified their risk for incident asthma within 18 months post infection.
Melatonin Not Supported to Treat ICU Delirium, SCD; Other Agents May Hold Promise
Researchers examined research on various interventions for treating sleep and circadian disruption (SCD) in the ICU and how they affected ICU delirium.
Inadequate Social Support in COPD Is Linked to Worse Clinical Outcomes
Researchers assessed patients with COPD living with loved ones to determine the patient’s perceived level of support for their illness.
Pneumococcal Vaccination Improves CAP Mortality in Older Patients
Investigators evaluated the real-world effects of prior pneumococcal vaccination in patients 65 years of age and older with community-acquired pneumonia.